Mourad Sanhaji

10PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 28, 2026
Correction: Raab et al. Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer. Cancers 2025, 17, 1910.

|Jun 26, 2025
Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer.

Monika Raab, Khayal Gasimli, Balázs Győrffy

|Jan 11, 2024
Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors.

Khayal Gasimli, Monika Raab, Ranadip Mandal

|Nov 26, 2022
Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy.

Maximilian Fleischmann, Ranadip Mandal, Izabela Kostova

|Nov 18, 2022
The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer.

Ranadip Mandal, Monika Raab, Franz Rödel

|Sep 23, 2022
Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRAS Amplification.

Khayal Gasimli, Monika Raab, Morva Tahmasbi Rad

Pageof 2

Frequent Collaborators

8 joint publications

Klaus Strebhardt

5 joint publications

Samuel Peña-Llopis

4 joint publications

Khayal Gasimli

4 joint publications

Ranadip Mandal